CA2472603A1 - Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate - Google Patents

Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate Download PDF

Info

Publication number
CA2472603A1
CA2472603A1 CA002472603A CA2472603A CA2472603A1 CA 2472603 A1 CA2472603 A1 CA 2472603A1 CA 002472603 A CA002472603 A CA 002472603A CA 2472603 A CA2472603 A CA 2472603A CA 2472603 A1 CA2472603 A1 CA 2472603A1
Authority
CA
Canada
Prior art keywords
crystal form
hydrate
compound
ray diffraction
hemifumarate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002472603A
Other languages
English (en)
French (fr)
Inventor
Kenji Kamada
Akira Hiraide
Kaichiro Koyama
Hitoshi Shimizu
Gary H. Ward
Vandana K. Cheruvallath
Stephan Parent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2472603A1 publication Critical patent/CA2472603A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002472603A 2002-01-11 2003-01-14 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate Abandoned CA2472603A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002004680 2002-01-11
JP2002-004680 2002-01-11
JP2002076708 2002-03-19
JP2002-076708 2002-03-19
PCT/JP2003/000203 WO2003068793A1 (en) 2002-01-11 2003-01-14 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate

Publications (1)

Publication Number Publication Date
CA2472603A1 true CA2472603A1 (en) 2003-08-21

Family

ID=27736409

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002472603A Abandoned CA2472603A1 (en) 2002-01-11 2003-01-14 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate

Country Status (7)

Country Link
US (1) US20050176938A1 (enExample)
EP (1) EP1463743A1 (enExample)
JP (1) JP2005519934A (enExample)
AU (1) AU2003202137A1 (enExample)
CA (1) CA2472603A1 (enExample)
TW (1) TW200302830A (enExample)
WO (1) WO2003068793A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10339882A1 (de) * 2003-06-26 2005-01-13 Continental Teves Ag & Co. Ohg Hydraulikaggregat für schlupfgeregelte Bremsanlagen
US7141769B2 (en) * 2005-04-01 2006-11-28 Cem Corporation Spectroscopy-based real-time control for microwave-assisted chemistry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
JP3258914B2 (ja) * 1995-08-03 2002-02-18 中外製薬株式会社 エリスロマイシン誘導体の製造方法
ZA966601B (en) * 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
SK142000A3 (en) * 1997-07-08 2000-06-12 Biochemie Sa Erythromycin a oxime solvates

Also Published As

Publication number Publication date
TW200302830A (en) 2003-08-16
US20050176938A1 (en) 2005-08-11
JP2005519934A (ja) 2005-07-07
AU2003202137A1 (en) 2003-09-04
EP1463743A1 (en) 2004-10-06
WO2003068793A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
HU230717B1 (hu) Eljárás a 4"-es helyzetben szubsztituált 9-dezoxo-9a-aza-9a-homoeritromicin-A-származékok előállítására
US20200071350A1 (en) Salts and crystal forms of gaba-a positive allosteric modulator
ZA200301047B (en) New macrolides with antibacterial activity.
EP2448945B1 (en) Crystalline forms of prasugrel salts
RU2607083C2 (ru) Кристалл циклопептида высокой чистоты, а также способ его получения и его применение
KR20150001802A (ko) 피닥소마이신의 고상 형태 및 이의 제조 방법
US20120329819A1 (en) New crystalline form of pemetrexed disodium
JP2019512542A (ja) 結晶塩形態
CA2472603A1 (en) Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
US8722863B2 (en) Solid state forms of fidaxomycin and processes for preparation thereof
WO2022200426A1 (en) Preparation method of quinoline derivative compounds
US6465437B1 (en) Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
AU2006318238A1 (en) New pleuromutilin derivative and its use
CA3210595A1 (en) Solid forms of a 4h-pyran-4-one structured cyp11a1 inhibitor
EP2078014A2 (en) Crystalline and amorphous forms of tiagabine
JP2005519934A5 (enExample)
IL188400A (en) Crystalline forms of macrolide compounds endowed with antiinflammatory activity
CN117480170A (zh) 用于合成缬苯那嗪的方法
EP1408047B1 (en) Process for preparation of erythromycin compounds
MX2010011835A (es) Proceso para la produccion de compuesto que tiene actividad antagonista al receptor de npyy5 y cristal util.
MX2008000279A (en) Crystalline forms of macrolide compounds endowed with antiinflammatory activity

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued